文献速递炎症性肠病消化内镜

经会阴超声早期肠壁厚度改善预测活动性溃疡性结肠炎治疗成功

Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-25

这项单中心前瞻性研究纳入100例接受诱导治疗的活动性溃疡性结肠炎(UC)患者,评估经腹或经会阴超声早期变化能否预测第8周临床缓解。基线超声参数和生物标志物无预测价值,但经会阴超声测量的直肠肠壁厚度从基线至第1周的变化是第8周缓解的独立预测因子(每降低1mm的校正比值比为1.90,95%CI 1.22-2.95);在1周内未缓解亚组中,该变化的预测价值仍较高(AUC=0.77,95%CI 0.61-0.88)。

要点

  • 基线超声参数和生物标志物不能预测第8周缓解。
  • 经会阴超声直肠肠壁厚度第1周较基线降低与第8周缓解独立相关。
  • 1周内未缓解者中,该厚度变化的预测AUC仍达0.77。

核心结论

  • 经会阴超声测量的直肠肠壁厚度第1周改善可预测治疗成功,并可能有助于UC诱导治疗早期决策。

研究设计与样本

  • 单中心前瞻性研究,纳入100例接受诱导治疗的活动性UC患者,分析第8周临床缓解的超声预测因素,并与基线、第1周和第8周测量的粪钙卫蛋白和C反应蛋白比较。

主要发现

  • 100例中54例在第8周达到缓解。
  • 基线生物标志物和超声参数值不能预测缓解。
  • 经会阴超声测量的直肠肠壁厚度从基线至第1周的变化是第8周缓解的独立预测因子(每降低1mm的校正比值比为1.90,95%CI 1.22-2.95)。
  • 在1周内未达到缓解的患者亚组分析中,直肠肠壁厚度变化的预测价值仍较高(AUC=0.77,95%CI 0.61-0.88)。

关键数值与推荐

  • 临床缓解定义为患者报告结局-2≤1且无直肠出血亚评分。
  • 预测因素采用多变量回归模型和受试者工作特征曲线分析评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bowel ultrasonography is a non-invasive imaging tool that can repeatedly monitor ulcerative colitis (UC) activity. AIM: This study aimed to determine whether early transabdominal or transperineal ultrasonography changes can predict subsequent clinical response to induction therapy in patients with UC. METHODS: This single-centre prospective study explored ultrasonographic predictors for clinical remission (patient-reported outcome-2 ≤ 1 with no rectal bleeding subscore) at week 8 in patients with active UC who underwent induction therapy, in comparison with faecal calprotectin and C-reactive protein (measured at baseline, week 1 and week 8). Predictive factors were assessed using multivariable regression models and receiver-operating-characteristic curve analysis. RESULTS: A total of 100 patients were analysed, of which 54 achieved remission at week 8. Baseline biomarker and ultrasonographic-parameter values were not predictive of remission. Contrastingly, change from baseline to week 1 in rectal bowel wall thickness measured using transperineal ultrasonography was an independent predictor of remission by week 8 (adjusted odds ratio is associated with a 1-mm decrease: 1.90 [95% confidence interval, 1.22-2.95]). In a subgroup analysis of the patients who did not achieve remission in 1 week, the predictive value of change in rectal bowel wall thickness remained high (AUC = 0.77 [95% confidence interval, 0.61-0.88]). CONCLUSION: Improvement in rectal bowel wall thickness measured using transperineal ultrasonography at week 1 predicts treatment success and potentially facilitates decision making during the early course of induction therapy in UC.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sagami S, Kobayashi T, Aihara K, et al. Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis. Aliment Pharmacol Ther. 2022. PMID: 35218038. doi:10.1111/apt.16817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。